Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 664-666, 2003; 10.1373/49.4.664
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ladwig, P. M.
Right arrow Articles by Larson, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ladwig, P. M.
Right arrow Articles by Larson, T. S.
Related Collections
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2003;49:664-666.)
© 2003 American Association for Clinical Chemistry, Inc.

Technical Briefs

Capillary Electrophoresis Method to Measure p-Aminohippuric Acid in Urine and Plasma for the Assessment of Renal Plasma Flow

Paula M. Ladwig1, Jan H. Bergert1 and Timothy S. Larson1,2,a

Divisions of
1 Clinical Biochemistry and Immunology and
2 Nephrology, Mayo Clinic and Foundation, Rochester, MN 55905

aaddress correspondence to this author at: Mayo Clinic, 200 First Street SW, Rochester, MN 55905; fax 507-284-5470, e-mail larson.timothy@mayo.edu

The first 300 words of the full text of this article appear below.

p-Aminohippuric acid (PAH), a derivative of aminobenzoic acid, is almost completely extracted from the blood after a single passage by the kidney through a combination of glomerular filtration and proximal tubular secretion. On the basis of these properties, the renal clearance of intravenously administered PAH has been used as a measure of renal plasma flow (RPF) (1). PAH remains the "gold standard" for the noninvasive measurement of RPF in patients and study participants and may be useful for assessing the effect of disease states or pharmacologic agents on renal function.

The standard method for PAH measurement is a colorimetric assay of a diazotation reaction that is labor-intensive (2)(3). Because of the complexities of the standard colorimetric PAH assay, its measurement has often been confined to research or used only in specialized laboratories. Measurement of PAH in urine and plasma by HPLC has been described (4)(5)(6)(7), but it requires relatively large sample volumes and time-consuming extraction procedures. We recently found that capillary electrophoresis (CE) is an efficient, inexpensive, and reliable method for measurement of the nonradiolabeled iothalamate in urine and plasma samples for the assessment of glomerular filtration rate (8)(9). Analysis by CE is analytically faster than standard HPLC or colorimetric assays, requires less reagent preparation and smaller sample size, minimizes drug interferences, and improves test turnaround time. With the development of a method for PAH on CE, assays for both RPF and glomerular filtration rate could also be obtained with a single methodology. This report describes a new quantitative CE assay for PAH in urine and plasma and compares it with the standard colorimetric assay.

PAH was measured by CE on a Beckman Pace instrument using Beckman System Gold software, 50 . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.